Communiqués Kinarus Therapeutics Holding AG

Actions

CURE

CH0009115129

Marché Fermé - Swiss Exchange 17:35:40 20/08/2026			Varia. 5j.	Varia. 1 janv.
19,90 ^CHF	-0,25 %		+2,84 %	+23,39 %

26/04/24	Bourse Zurich: le SMI se maintient dans le vert avant l'inflation US	AW
26/04/24	Bourse Zurich: rebond dans les premiers échanges, l'inflation US attendue	AW

Communiqués

26/04/24	Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed	EQ
17/04/24	Kinarus Therapeutics : Q&A on the Reverse Share Split	PU
17/04/24	Kinarus Therapeutics : Q&A on the Reverse Share Split” unter Financial News / Corporate News ablegen	PU
17/04/24	Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split	EQ
01/03/24	Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis	EQ
28/02/24	Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023	EQ
06/02/24	Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG	EQ
29/01/24	Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation	EQ
25/09/23	Kinarus Therapeutics has decided to file for bankruptcy	EQ
30/08/23	Kinarus Therapeutics Group Reports First Half 2023 Financial Results	EQ
25/08/23	Kinarus Therapeutics signed licensing agreement to extend cash for operations	EQ
19/07/23	Kinarus Therapeutics : July 2023 Investor Presentation	PU
12/07/23	Kinarus Therapeutics Announces Personnel Changes	EQ
12/07/23	Kinarus Therapeutics Announces Personnel Change	AQ
29/06/23	Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	EQ
29/06/23	Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	AQ
27/06/23	Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity	EQ
27/06/23	Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity	AQ
02/06/23	Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting	EQ
02/06/23	Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting	AQ
31/05/23	Kinarus Therapeutics : Annual financial report 2022	PU
31/05/23	Kinarus Therapeutics Group Reports 2022 Annual Results	EQ
31/05/23	Kinarus Therapeutics Group Reports 2022 Annual Results	AQ
11/05/23	Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management	EQ
11/05/23	Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management	AQ